Authors

• Nicolas Clémenty (ORCID: https://orcid.org/0000-0002-7415-0787)
• Vikas Kuriachan (ORCID: https://orcid.org/0000-0001-9032-3628)
• Christopher Wiggenhorn
• Ian Crozier (ORCID: https://orcid.org/0000-0003-4652-7791)
• Laurence Mark Epstein (ORCID: https://orcid.org/0000-0001-5410-0291)
• Jeff Lande (ORCID: https://orcid.org/0000-0002-9584-610X)
• Gregory Engel (ORCID: https://orcid.org/0000-0001-9481-6913)
• Marianne Gwechenberger (ORCID: https://orcid.org/0000-0002-3066-8947)
• David Duncker (ORCID: https://orcid.org/0000-0003-2996-6338)
• Lucas V.A. Boersma (ORCID: https://orcid.org/0000-0003-4591-4220)
• Camille Frazier‐Mills
• Nobuhiro Nishii (ORCID: https://orcid.org/0000-0003-3183-5660)
• Anish K. Amin (ORCID: https://orcid.org/0000-0001-6432-1573)

Institutions

• Okayama University (JP)
• University of Calgary (CA)
• Riverside Methodist Hospital (US)
• North Shore University Hospital (US)
• Christchurch Hospital (NZ)
• Medizinische Hochschule Hannover (DE)
• Medtronic (United States) (US)
• Clinique du Millénaire (FR)
• St. Antonius Ziekenhuis (NL)
• Duke Medical Center (US)
• Amsterdam University Medical Centers (NL)
• Medical University of Vienna (AT)

Publication Details

Journal

Heart Rhythm O2

Published

2024-10-16

DOI

https://doi.org/10.1016/j.hroo.2024.09.022

Citations

7

Primary Topic

Cardiac pacing and defibrillation studies

Type

article

Field-Weighted Citation Impact

2.81

Funders

• Bristol-Myers Squibb
• Pfizer
• AstraZeneca
• Sanofi
• Medtronic
• AtriCure
• Boston Scientific Corporation
• Servier
• MicroPort
• Biosense Webster
• Daiichi Sankyo Europe